Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DRTS
DRTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DRTS News
Positive Results for Alpha DaRT Treatment in Pancreatic Cancer
1d ago
Newsfilter
Alpha Tau Reports Q1 Loss Exceeding Estimates Amid Clinical Study Updates
May 19 2026
stocktwits
Alpha Tau Medical Reports Wider Q1 Loss and Milestones
May 19 2026
NASDAQ.COM
Alpha Tau Medical Reports Q1 2026 Financial Results
May 18 2026
seekingalpha
Alpha Tau Medical Announces Investor Conference Participation
May 18 2026
Newsfilter
Alpha Tau Medical Reports Promising Trial Results for Glioblastoma Treatment
May 11 2026
stocktwits
Alpha Tau Medical Shares Surge 12% on Positive Glioblastoma Trial Results
May 11 2026
NASDAQ.COM
Trump Rejects Iran's Revised Proposal Amid Geopolitical Tensions
May 11 2026
stocktwits
Alpha Tau Medical to Discuss Interim Data on Brain Cancer Treatment
May 11 2026
stocktwits
Alpha Tau Announces Interim Clinical Data for Alpha DaRT
May 08 2026
Newsfilter
Alpha Tau Completes Enrollment in Pivotal U.S. Trial
May 08 2026
Newsfilter
Alpha Tau Medical Presents New Therapy at Head and Neck Cancer Conference
May 05 2026
Newsfilter
Alpha DaRT Achieves Milestone in Pancreatic Cancer Trials
May 04 2026
Newsfilter
ALPHA TAU REPORTS COMPLETE LOCAL DISEASE CONTROL AND POSITIVE SAFETY PROFILE IN ALPHA DART® PANCREATIC CANCER TRIALS SHOWCASED AT DDW 2026
May 04 2026
moomoo
Alpha Tau Medical Announces Key Research Accepted at ASCO Annual Meeting
Apr 27 2026
Newsfilter
Alpha Tau Medical Advances Pancreatic Cancer Research with Trial Expansion
Apr 24 2026
stocktwits
Show More News
